Valeant Pharmaceuticals has filed its long-overdue financial report for 2015, plus restated results for several quarters, resolving its default on some of its $30 billion in debt and averting other problems
ABC News: Money, ABC News: Business
Fri, 04/29/2016 - 7:13am
Valeant Pharmaceuticals has filed its long-overdue financial report for 2015, plus restated results for several quarters, resolving its default on some of its $30 billion in debt and averting other problems